作者
Thomas J Wang, Debby Ngo, Nikolaos Psychogios, Andre Dejam, Martin G Larson, Ramachandran S Vasan, Anahita Ghorbani, John O’Sullivan, Susan Cheng, Eugene P Rhee, Sumita Sinha, Elizabeth McCabe, Caroline S Fox, Christopher J O’Donnell, Jennifer E Ho, Jose C Florez, Martin Magnusson, Kerry A Pierce, Amanda L Souza, Yi Yu, Christian Carter, Peter E Light, Olle Melander, Clary B Clish, Robert E Gerszten
发表日期
2013/10/1
期刊
The Journal of clinical investigation
卷号
123
期号
10
页码范围
4309-4317
出版商
American Society for Clinical Investigation
简介
Improvements in metabolite-profiling techniques are providing increased breadth of coverage of the human metabolome and may highlight biomarkers and pathways in common diseases such as diabetes. Using a metabolomics platform that analyzes intermediary organic acids, purines, pyrimidines, and other compounds, we performed a nested case-control study of 188 individuals who developed diabetes and 188 propensity-matched controls from 2,422 normoglycemic participants followed for 12 years in the Framingham Heart Study. The metabolite 2-aminoadipic acid (2-AAA) was most strongly associated with the risk of developing diabetes. Individuals with 2-AAA concentrations in the top quartile had greater than a 4-fold risk of developing diabetes. Levels of 2-AAA were not well correlated with other metabolite biomarkers of diabetes, such as branched chain amino acids and aromatic amino acids …
引用总数
20132014201520162017201820192020202120222023202422239493736405951484522
学术搜索中的文章
TJ Wang, D Ngo, N Psychogios, A Dejam, MG Larson… - The Journal of clinical investigation, 2013